Phase I/II – Other

643 trials 280 recruiting

Filter these 643 trials by condition, country, sponsor and more.

Open in Search →

Phase 1b/2 Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination with Carboplatin, Pemetrexed and … Pending

2025-521989-95-00 Advanced/Metastatic Non-squamous Non-Small Cell Lung Ca
Locating microclots with PET in post-COVID syndrome Pending

2025-522348-42-00 post-COVID syndrome (long COVID)
Phase I-IIa, national, multicenter, clinical trial to evaluate the safety and preliminary efficacy of CAR-T CD19 therapy in patients with re… Pending

2025-522449-23-00 Refractory Lupus Nephritis
OVACURE-2 Pending

2025-522659-24-00 Ovarian carcinoma
A Phase 1/2 Study of Inhaled KB707 in Patients Pending

2025-522723-98-00 solid tumor
Evaluation of a new radiotracker for predicting complete response after neoadjuvant chemotherapy in HER2-positive early breast cancer Pending

2025-523286-23-00 Breast Cancer
A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients with Advanced KRAS … Pending

2025-523432-39-01 Advanced KRAS G12D-Mutant Solid Tumors
Study with IDE849 for patients with DLL3 positive cancer, including small cell lung cancer Pending

2025-523438-24-00 DLL3 Expressing Tumors Including Small Cell Lung Cancer
Symbiotic-GI-13, A Study to Learn About the Study Medicine Called PF-08634404 as Monotherapy and Combination Therapy in Adult Participants w… Pending

2025-523525-17-00 Unresectable Locally Advanced or Metastatic Hepatocellu
A Study to Learn about the Study Medicine called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers Pending

2025-523526-40-00 Advanced Solid Tumors
Rollover study for participants who are currently being treated with and are continuing to benefit from opnurasib as a single agent or in co… Pending

2025-523537-26-00 Locally advanced or metastatic KRAS G12C-mutated non-sm
PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending

2025-524613-89-00 HER2 positive advanced breast cancer
A Research Study Testing New Cancer Medicines Used Alone or Together to Treat Solid Tumors Pending

2025-524623-50-00 Solid Tumors
IL-1β blockade to prevent Immunothrombosis in recipients of a Pancreatic Organ (ILIPO) Pending

2025-524834-24-00 diabetic patients pancreatic transplant
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab… Pending

2026-525248-13-00 Advanced Solid Tumors
The headache- and migraine-inducing effects of pitolisant in women with migraine without aura Pending

2026-525521-20-00 Migraine without aura
A Phase 1b-2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of LRK-4189 Alone and … Pending

2026-525629-20-00 Solid tumors
The headache- and migraine-inducing effects of apremilast in women with migraine without aura Pending

2026-525987-16-00 Migraine without aura
Clinical trial with dasatinib for the prevention of CAR-T side effects in patients with relapsed or treatment-resistant multiple myeloma und… Pending

2023-507537-16-00 Chimeric antigen receptor T cell therapy-associated cyt
BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending

2024-516115-24-00 High risk relapsed neuroblastoma (relapsed or progresse
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus standard temozolomide … Pending

2024-516357-46-00 Glioblastoma
Anti-CD 19 CAR-T cell therapy in patients with ANCA Vasculitis - the IDEAL trial Pending

2024-517303-36-00 ANCA-IgG-positive ANCA associated vasculitis
Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma pat… Pending

2024-518199-30-00 Soft tissue sarcoma patients
uPAR PET/MRI in glioma Pending

2024-519723-20-01 Glioma